1 mg, 5 mg and 10 mg à 20 ml x 1 vial infusion liquid, clear, colorless to slightly yellow solution, mainly free of visible particles.
Treatment of idiopathic or hereditary pulmonary arterial hypertension (PAH) to increase exercise tolerance and reduce disease symptoms in patients classified as New York Heart Association (NYHA) class III.
Mechanism of action
Treprostinil is a prostacyclin analogue. It exerts a direct vasodilating effect on the pulmonary and systemic circulation, and inhibits platelet aggregation systemic.the circulation
and inhibits platelet aggregation.
No special temperature instructions, stored in the original box and light sensitive.
Contains 1 vial.
Vnr: 412384 1 mg, 20 ml vial
Vnr: 093904 5 mg, 20 ml vial
Vnr: 092599 10 mg, 20 ml vial
For more information and educational materials:
The page was last updated on 21/09/2020